IMPEDIMED LIMITED - Announcements

2.22%

4.4¢

Market Cap $89.31M

Technology Scientific & Technical Instruments

ImpediMed Limited is an Australia-based medical technology company. The Company uses... ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. SOZO uses its BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IPD	Appendix 4D & Interim Financial Report 31 December 2014	PRICE SENSITIVE	25/02/15	838.52KB	Share
IPD	Appendix 3B		20/02/15	231.66KB	Share
IPD	Additional Major Oncology Centres in US L-Dex Program		03/02/15	79.91KB	Share
IPD	Appendix 4C - Quarter ended 31 December 2014	PRICE SENSITIVE	28/01/15	263.39KB	Share
IPD	Company Secretary Appointment		08/01/15	149.12KB	Share
IPD	Appendix 3B		08/01/15	230.79KB	Share
IPD	Becoming a substantial holder		29/12/14	213.53KB	Share
IPD	Annual Report correction re Option Terms		19/12/14	175.64KB	Share
IPD	Appendix 3B		19/12/14	521.3KB	Share
IPD	Change of Director's Interest Notice		19/12/14	240.04KB	Share
IPD	Change of Director's Interest Notice		19/12/14	239.26KB	Share
IPD	Change of Director's Interest Notice		19/12/14	303.46KB	Share
IPD	Becoming a substantial holder		18/12/14	48.57KB	Share
IPD	Appendix 3B		11/12/14	181.69KB	Share
IPD	Completion of non-renounceable entitlement offer		10/12/14	48.11KB	Share
IPD	Appendix 3B		03/12/14	551.2KB	Share
IPD	Change of Director's Interest Notice		26/11/14	408.19KB	Share
IPD	Despatch of Offer Booklet		24/11/14	2.18MB	Share
IPD	Shares to be issued under Entitlement Offer		20/11/14	50.45KB	Share
IPD	Major US Oncology Centre in Commercial L-Dex Program	PRICE SENSITIVE	14/11/14	80.21KB	Share
IPD	Cleansing Notice		13/11/14	145.3KB	Share
IPD	Entitlement Offer Notice to Option Holders		13/11/14	140.94KB	Share
IPD	Entitlement Offer Notice Ineligible Shareholders		13/11/14	145.43KB	Share
IPD	Entitlement Offer Notice to Shareholders		13/11/14	157.34KB	Share
IPD	Appendix 3B		13/11/14	72.7KB	Share
IPD	Offer Booklet	PRICE SENSITIVE	13/11/14	586.33KB	Share
IPD	Underwritten Entitlement Offer	PRICE SENSITIVE	13/11/14	164.66KB	Share
IPD	Appendix 3B		13/11/14	68.9KB	Share
IPD	Investor Update		11/11/14	3.96MB	Share
IPD	Trading Halt	PRICE SENSITIVE	11/11/14	260.67KB	Share
IPD	Appendix 3B		06/11/14	916.87KB	Share
IPD	Medicare Payment Open Briefing		04/11/14	223.05KB	Share
IPD	Medicare payment for new L-Dex Category I code announced	PRICE SENSITIVE	03/11/14	90.93KB	Share
IPD	Results of Meeting		30/10/14	133.2KB	Share
IPD	Chairman's Address to Shareholders		30/10/14	190.04KB	Share
IPD	AGM Presentation		30/10/14	1.45MB	Share
IPD	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/14	273.58KB	Share
IPD	Appendix 3B		14/10/14	920.5KB	Share
IPD	Notice of Annual General Meeting/Proxy Form		26/09/14	2.06MB	Share
IPD	Annual Report to shareholders		26/09/14	3.52MB	Share
IPD	Dr Frank Vicini appointed Chief Medical Officer		08/09/14	225.37KB	Share
IPD	CEO discusses receipt of reimbursement code descriptor		04/09/14	224.3KB	Share
IPD	L-Dex granted reimbursement status for all cancer related Ly	PRICE SENSITIVE	03/09/14	172.29KB	Share
IPD	Trading Halt	PRICE SENSITIVE	03/09/14	257.56KB	Share
IPD	Full Year Statutory Accounts		27/08/14	1.35MB	Share
IPD	Preliminary Final Report	PRICE SENSITIVE	27/08/14	147.32KB	Share
IPD	Investor Presentation - Canaccord Boston Conference		14/08/14	3MB	Share
IPD	Reimbursement Strategy in BRR audio broadcast		08/08/14	215.04KB	Share
IPD	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/14	272.82KB	Share
IPD	Macquarie University Cancer Institute L-Dex Trial Site	PRICE SENSITIVE	23/07/14	268.75KB	Share
IPD	Corporate Presentation		21/07/14	3.02MB	Share
IPD	International Post-approval Clinical Trial commences	PRICE SENSITIVE	26/06/14	82.23KB	Share
IPD	Change of Director's Interest Notice		14/05/14	423.72KB	Share
IPD	Change of Director's Interest Notice		13/05/14	280.74KB	Share
IPD	Change of Director's Interest Notice		13/05/14	279.84KB	Share
IPD	Change of Director's Interest Notice		09/05/14	474.6KB	Share
IPD	Change of Director's Interest Notice		09/05/14	422.75KB	Share
IPD	Change of Director's Interest Notice		05/05/14	381.5KB	Share
IPD	Change of Director's Interest Notice		05/05/14	239.02KB	Share
IPD	L-Dex featured at key international conference		05/05/14	255.33KB	Share
IPD	Appendix 3B		02/05/14	625.43KB	Share
IPD	Appendix 3B		30/04/14	550.29KB	Share
IPD	A$2.35 Million Raised Under Share Purchase Plan		30/04/14	19.59KB	Share
IPD	Appendix 4C - quarterly	PRICE SENSITIVE	22/04/14	189.47KB	Share
IPD	ASX Listing Rule 3.10.5A Announcement		04/04/14	71.58KB	Share
IPD	Share Purchase Plan Offer		04/04/14	1.52MB	Share
IPD	Cleansing Notice		04/04/14	69.85KB	Share
IPD	Appendix 3B		04/04/14	627.59KB	Share
IPD	Successful A$8.8 Million Placement	PRICE SENSITIVE	28/03/14	23.19KB	Share
IPD	Trading Halt	PRICE SENSITIVE	26/03/14	354.34KB	Share
IPD	Investor Presentation		19/03/14	3.1MB	Share
IPD	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/14	157.64KB	Share
IPD	Appendix 3B		28/01/14	546.18KB	Share
IPD	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/14	443.01KB	Share
IPD	Investor Presentation Update		14/01/14	2.21MB	Share
IPD	Nutrition and Body Composition	PRICE SENSITIVE	17/12/13	23.67KB	Share
IPD	Change of Director's Interest Notice		09/12/13	407.23KB	Share
IPD	Curie Clinical Trial Service Agreement signed	PRICE SENSITIVE	28/11/13	22.44KB	Share
IPD	Change of Director's Interest Notice		18/11/13	423.1KB	Share
IPD	Investor Presentation Update		13/11/13	1.88MB	Share
IPD	AMA accepts Category 1 CPT Code	PRICE SENSITIVE	13/11/13	93.41KB	Share
IPD	Final Director's Interest Notice		11/11/13	248.71KB	Share
IPD	Initial Director's Interest Notice		11/11/13	193.58KB	Share
IPD	Results of Meeting		11/11/13	131.79KB	Share
IPD	Chairman's Address to Shareholders		11/11/13	146.93KB	Share
IPD	Second US Director Appointed		11/11/13	88.73KB	Share
IPD	AGM Investor Presentation		08/11/13	1.35MB	Share
IPD	Pivotal Clinical Trial Investigators Announced		30/10/13	73.73KB	Share
IPD	Appendix 3B		28/10/13	584.56KB	Share
IPD	Appendix 4C - quarterly	PRICE SENSITIVE	24/10/13	1.27MB	Share
IPD	Investor Presentation		14/10/13	1.74MB	Share
IPD	Large US Healthcare Provider expands L-Dex use	PRICE SENSITIVE	09/10/13	91.51KB	Share
IPD	Notice of Annual General Meeting/Proxy Form		08/10/13	676.95KB	Share
IPD	Second US Director Appointment & Director Retirement		08/10/13	99.88KB	Share
IPD	Final Director's Interest Notice		03/10/13	191.85KB	Share
IPD	Annual Report to shareholders		27/09/13	3.3MB	Share
IPD	Board and Executive Management Changes		20/09/13	83.26KB	Share
IPD	Full Year Statutory Accounts		28/08/13	672.82KB	Share
IPD	Preliminary Final Report	PRICE SENSITIVE	28/08/13	37.14KB	Share
IPD	Investor Presentation		19/08/13	1.55MB	Share

IPD Appendix 4D & Interim Financial Report 31 December 2014
25/02/15	PRICE SENSITIVE	838.52KB	Share
IPD Appendix 3B
20/02/15		231.66KB	Share
IPD Additional Major Oncology Centres in US L-Dex Program
03/02/15		79.91KB	Share
IPD Appendix 4C - Quarter ended 31 December 2014
28/01/15	PRICE SENSITIVE	263.39KB	Share
IPD Company Secretary Appointment
08/01/15		149.12KB	Share
IPD Appendix 3B
08/01/15		230.79KB	Share
IPD Becoming a substantial holder
29/12/14		213.53KB	Share
IPD Annual Report correction re Option Terms
19/12/14		175.64KB	Share
IPD Appendix 3B
19/12/14		521.3KB	Share
IPD Change of Director's Interest Notice
19/12/14		240.04KB	Share
IPD Change of Director's Interest Notice
19/12/14		239.26KB	Share
IPD Change of Director's Interest Notice
19/12/14		303.46KB	Share
IPD Becoming a substantial holder
18/12/14		48.57KB	Share
IPD Appendix 3B
11/12/14		181.69KB	Share
IPD Completion of non-renounceable entitlement offer
10/12/14		48.11KB	Share
IPD Appendix 3B
03/12/14		551.2KB	Share
IPD Change of Director's Interest Notice
26/11/14		408.19KB	Share
IPD Despatch of Offer Booklet
24/11/14		2.18MB	Share
IPD Shares to be issued under Entitlement Offer
20/11/14		50.45KB	Share
IPD Major US Oncology Centre in Commercial L-Dex Program
14/11/14	PRICE SENSITIVE	80.21KB	Share
IPD Cleansing Notice
13/11/14		145.3KB	Share
IPD Entitlement Offer Notice to Option Holders
13/11/14		140.94KB	Share
IPD Entitlement Offer Notice Ineligible Shareholders
13/11/14		145.43KB	Share
IPD Entitlement Offer Notice to Shareholders
13/11/14		157.34KB	Share
IPD Appendix 3B
13/11/14		72.7KB	Share
IPD Offer Booklet
13/11/14	PRICE SENSITIVE	586.33KB	Share
IPD Underwritten Entitlement Offer
13/11/14	PRICE SENSITIVE	164.66KB	Share
IPD Appendix 3B
13/11/14		68.9KB	Share
IPD Investor Update
11/11/14		3.96MB	Share
IPD Trading Halt
11/11/14	PRICE SENSITIVE	260.67KB	Share
IPD Appendix 3B
06/11/14		916.87KB	Share
IPD Medicare Payment Open Briefing
04/11/14		223.05KB	Share
IPD Medicare payment for new L-Dex Category I code announced
03/11/14	PRICE SENSITIVE	90.93KB	Share
IPD Results of Meeting
30/10/14		133.2KB	Share
IPD Chairman's Address to Shareholders
30/10/14		190.04KB	Share
IPD AGM Presentation
30/10/14		1.45MB	Share
IPD Appendix 4C - quarterly
27/10/14	PRICE SENSITIVE	273.58KB	Share
IPD Appendix 3B
14/10/14		920.5KB	Share
IPD Notice of Annual General Meeting/Proxy Form
26/09/14		2.06MB	Share
IPD Annual Report to shareholders
26/09/14		3.52MB	Share
IPD Dr Frank Vicini appointed Chief Medical Officer
08/09/14		225.37KB	Share
IPD CEO discusses receipt of reimbursement code descriptor
04/09/14		224.3KB	Share
IPD L-Dex granted reimbursement status for all cancer related Ly
03/09/14	PRICE SENSITIVE	172.29KB	Share
IPD Trading Halt
03/09/14	PRICE SENSITIVE	257.56KB	Share
IPD Full Year Statutory Accounts
27/08/14		1.35MB	Share
IPD Preliminary Final Report
27/08/14	PRICE SENSITIVE	147.32KB	Share
IPD Investor Presentation - Canaccord Boston Conference
14/08/14		3MB	Share
IPD Reimbursement Strategy in BRR audio broadcast
08/08/14		215.04KB	Share
IPD Appendix 4C - quarterly
30/07/14	PRICE SENSITIVE	272.82KB	Share
IPD Macquarie University Cancer Institute L-Dex Trial Site
23/07/14	PRICE SENSITIVE	268.75KB	Share
IPD Corporate Presentation
21/07/14		3.02MB	Share
IPD International Post-approval Clinical Trial commences
26/06/14	PRICE SENSITIVE	82.23KB	Share
IPDChange of Director's Interest Notice
14/05/14		423.72KB	Share
IPDChange of Director's Interest Notice
13/05/14		280.74KB	Share
IPDChange of Director's Interest Notice
13/05/14		279.84KB	Share
IPDChange of Director's Interest Notice
09/05/14		474.6KB	Share
IPDChange of Director's Interest Notice
09/05/14		422.75KB	Share
IPDChange of Director's Interest Notice
05/05/14		381.5KB	Share
IPDChange of Director's Interest Notice
05/05/14		239.02KB	Share
IPDL-Dex featured at key international conference
05/05/14		255.33KB	Share
IPDAppendix 3B
02/05/14		625.43KB	Share
IPDAppendix 3B
30/04/14		550.29KB	Share
IPDA$2.35 Million Raised Under Share Purchase Plan
30/04/14		19.59KB	Share
IPDAppendix 4C - quarterly
22/04/14	PRICE SENSITIVE	189.47KB	Share
IPDASX Listing Rule 3.10.5A Announcement
04/04/14		71.58KB	Share
IPDShare Purchase Plan Offer
04/04/14		1.52MB	Share
IPDCleansing Notice
04/04/14		69.85KB	Share
IPDAppendix 3B
04/04/14		627.59KB	Share
IPDSuccessful A$8.8 Million Placement
28/03/14	PRICE SENSITIVE	23.19KB	Share
IPDTrading Halt
26/03/14	PRICE SENSITIVE	354.34KB	Share
IPDInvestor Presentation
19/03/14		3.1MB	Share
IPDHalf Yearly Report and Accounts
26/02/14	PRICE SENSITIVE	157.64KB	Share
IPDAppendix 3B
28/01/14		546.18KB	Share
IPDAppendix 4C - quarterly
28/01/14	PRICE SENSITIVE	443.01KB	Share
IPDInvestor Presentation Update
14/01/14		2.21MB	Share
IPDNutrition and Body Composition
17/12/13	PRICE SENSITIVE	23.67KB	Share
IPDChange of Director's Interest Notice
09/12/13		407.23KB	Share
IPDCurie Clinical Trial Service Agreement signed
28/11/13	PRICE SENSITIVE	22.44KB	Share
IPDChange of Director's Interest Notice
18/11/13		423.1KB	Share
IPDInvestor Presentation Update
13/11/13		1.88MB	Share
IPDAMA accepts Category 1 CPT Code
13/11/13	PRICE SENSITIVE	93.41KB	Share
IPDFinal Director's Interest Notice
11/11/13		248.71KB	Share
IPDInitial Director's Interest Notice
11/11/13		193.58KB	Share
IPDResults of Meeting
11/11/13		131.79KB	Share
IPDChairman's Address to Shareholders
11/11/13		146.93KB	Share
IPDSecond US Director Appointed
11/11/13		88.73KB	Share
IPDAGM Investor Presentation
08/11/13		1.35MB	Share
IPDPivotal Clinical Trial Investigators Announced
30/10/13		73.73KB	Share
IPDAppendix 3B
28/10/13		584.56KB	Share
IPDAppendix 4C - quarterly
24/10/13	PRICE SENSITIVE	1.27MB	Share
IPDInvestor Presentation
14/10/13		1.74MB	Share
IPDLarge US Healthcare Provider expands L-Dex use
09/10/13	PRICE SENSITIVE	91.51KB	Share
IPDNotice of Annual General Meeting/Proxy Form
08/10/13		676.95KB	Share
IPDSecond US Director Appointment & Director Retirement
08/10/13		99.88KB	Share
IPDFinal Director's Interest Notice
03/10/13		191.85KB	Share
IPDAnnual Report to shareholders
27/09/13		3.3MB	Share
IPDBoard and Executive Management Changes
20/09/13		83.26KB	Share
IPDFull Year Statutory Accounts
28/08/13		672.82KB	Share
IPDPreliminary Final Report
28/08/13	PRICE SENSITIVE	37.14KB	Share
IPDInvestor Presentation
19/08/13		1.55MB	Share

REFRESH

First 9 10 11 12 13

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.4¢		Change -0.001(2.22%)		Mkt cap ! $89.31M

Open	High	Low	Value	Volume
4.4¢	4.4¢	4.3¢	$176.4K	4.014M

Buyers (Bids)

No.	Vol.	Price($)
1	60000	4.3¢

Sellers (Offers)

Price($)	Vol.	No.
4.4¢	185799	1

View Market Depth

No.	Vol.	Price($)
1	60000	0.043
2	225000	0.042
3	538792	0.041
7	474500	0.040
5	235450	0.039

Price($)	Vol.	No.
0.044	185799	1
0.045	914690	4
0.046	118838	1
0.047	237551	2
0.050	70000	2

Last trade - 13.14pm 12/08/2025 (20 minute delay)

IPD (ASX) Chart

IMPEDIMED LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available